950651-11-3 Usage
Class
Acetamide
Molecular Structure
Contains an amino group (-NH2), a phenyl group with a trifluoromethoxy substituent (-OCH3), and an acetamide functional group (-CONH2)
Applications
Used in medicinal chemistry for synthesizing pharmaceuticals
Utilized in research and development in organic chemistry
Properties
Functional Groups: Contains an amino group, a phenyl group with a trifluoromethoxy substituent, and an acetamide functional group
Biological Activity: Its unique structure makes it a valuable building block for creating biologically active molecules and drugs
Significance
Important compound in the pharmaceutical industry for drug development and synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 950651-11-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,0,6,5 and 1 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 950651-11:
(8*9)+(7*5)+(6*0)+(5*6)+(4*5)+(3*1)+(2*1)+(1*1)=163
163 % 10 = 3
So 950651-11-3 is a valid CAS Registry Number.
950651-11-3Relevant articles and documents
NITROGENATED HETEROCYCLIC COMPOUND
-
, (2015/03/28)
The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof.
COMPOUNDS WHICH INHIBIT THE GLYCINE TRANSPORTER AND USES THEREOF
-
Page/Page column 37, (2008/06/13)
Compounds of formula (I) and salts and solvates thereof are provided: wherein R1 to R8 and n are defined in the description. Uses of the compounds as medicaments, and in the manufacture of medicament for treating neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder are also disclosed. The invention further comprises processes to make these compounds and pharmaceutical formulations thereof.